Corporate & Background
 Custom Manufacturing
 Business & Products
Businesses
Products
Generic API's
Intermediates
Peptide Building Blocks
Carotenoids (Synthetic) and Nutraceuticals
Future Generics
 Facilities & Strengths
 Ethics & Values
 Regulatory Submissions
 Investors & Financials
 Sustainability
 Careers
 Locations & Contact
 Media Center
 Enquiry
 Home
     Our Nutraceuticals website
      News & Events

Divis manufacture API's for the Generics. As a company Divis understand that sustained development is not possible without respecting to IPR. Divis takes great care to ensure that its product or processes do not infringe valid patents.

Divis is actively involved in developing alternate, patent non-infringing processes for APIs, for the inventors to manage late life cycle and leading generic drug manufacturers.

Product Name Structure
BUPROPION HBr

CAS No : 905818-69-1
Capecitabine

CAS No : 154361-50-9
CARBIDOPA

CAS No : 28860-95-9
Dextromethorphan HBr

CAS No: 6700-34-1
Diltiazem HCl

CAS No : 33286-22-5
Entacapone

CAS No : 130929-57-6
Fosphenytoin sodium

CAS No: 92134-98-0
Gabapentin

CAS No : 60142-96-3
Iopamidol

CAS No : 60166-93-0
Irbesartan

CAS No : 138402-11-6
Levetiracetam

CAS No : 102767-28-2
Levodopa

CAS No : 59-92-7
Losartan potassium

CAS No : 124750-99-8
Lurasidone HCl

CAS No : 367514-88-3
Mesalamine

CAS No : 89-57-6
Nabumetone

CAS No : 42924-53-8
NAPROXEN

CAS No [22204-53-1]
NAPROXEN SODIUM

CAS No [26159-34-2]
NIACIN

CAS No : 59-67-6
Orlistat

CAS No : 96829-58-2
Olmesartan medoxomil

CAS No : 144689-63-4
PHENYLEPHRINE HCl

CAS No [61-76-7]
Pregabalin

CAS No: 148553-50-8
Proguanil HCl

CAS No: 637-32-1
QUETIAPINE FUMARATE

CAS No [111974-72-2]
TAMSULOSIN HCl

CAS No [106463-17-6]
TELMISARTAN

CAS No : 144701-48-4
TRIPROLIDINE HCl

CAS No : 6138-79-0
VALACYCLOVIR HCl

CAS No :124832-27-5
VALSARTAN

CAS No :60643-86-9
VENLAFAXINE HCl

CAS No : 99300-78-4
VIGABATRIN

CAS No : 163521-08-2
Vilazodone HCl

CAS No : 163521-08-2
Disclaimer: Products covered by valid patents are not offered for commercial use.It is the buyers responsibility to ensure the transactions do not infringe any patent rights applicable
top
Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved     Web design london